Jeremy S Brown
Overview
Explore the profile of Jeremy S Brown including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
3270
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chan J, Ramos-Sevillano E, Betts M, Wilson H, Weight C, Houhou-Ousalah A, et al.
Infect Immun
. 2024 Apr;
92(5):e0044723.
PMID: 38629841
, a common colonizer of the upper respiratory tract, invades nasopharyngeal epithelial cells without causing disease in healthy participants of controlled human infection studies. We hypothesized that surface expression of...
12.
Polverino E, Soyza A, Dimakou K, Traversi L, Bossios A, Crichton M, et al.
Am J Respir Crit Care Med
. 2024 Jan;
210(1):119-127.
PMID: 38271696
COPD and bronchiectasis are commonly reported together. Studies report varying impacts of co-diagnosis on outcomes, which may be related to different definitions of disease used across studies. To investigate the...
13.
Obolski U, Swarthout T, Kalizangoma A, Mwalukomo T, Chan J, Weight C, et al.
Nat Commun
. 2023 Nov;
14(1):7477.
PMID: 37978177
Streptococcus pneumoniae causes substantial mortality among children under 5-years-old worldwide. Polysaccharide conjugate vaccines (PCVs) are highly effective at reducing vaccine serotype disease, but emergence of non-vaccine serotypes and persistent nasopharyngeal...
14.
Hill H, Mitsi E, Nikolaou E, Blizard A, Pojar S, Howard A, et al.
Am J Respir Crit Care Med
. 2023 Aug;
208(8):868-878.
PMID: 37556679
Pneumococcal pneumonia remains a global health problem. Pneumococcal colonization increases local and systemic protective immunity, suggesting that nasal administration of live attenuated (Spn) strains could help prevent infections. We used...
15.
Zheng B, Vivaldi G, Daines L, Leavy O, Richardson M, Elneima O, et al.
Lancet Reg Health Eur
. 2023 Jun;
29:100635.
PMID: 37261214
Background: The risk factors for recovery from COVID-19 dyspnoea are poorly understood. We investigated determinants of recovery from dyspnoea in adults with COVID-19 and compared these to determinants of recovery...
16.
Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19
Daines L, Zheng B, Elneima O, Harrison E, Lone N, Hurst J, et al.
ERJ Open Res
. 2023 Feb;
9(1).
PMID: 36820079
Background: Persistence of respiratory symptoms, particularly breathlessness, after acute coronavirus disease 2019 (COVID-19) infection has emerged as a significant clinical problem. We aimed to characterise and identify risk factors for...
17.
Gil E, Wall E, Noursadeghi M, Brown J
Front Cell Infect Microbiol
. 2023 Jan;
12:1106596.
PMID: 36683708
(SPN) is a globally significant cause of meningitis, the pathophysiology of which involves damage to the brain by both bacterial virulence factors and the host inflammatory response. In most cases...
18.
19.
Zheng B, Daines L, Han Q, Hurst J, Pfeffer P, Shankar-Hari M, et al.
Eur Respir Rev
. 2022 Nov;
31(166.
PMID: 36323418
Persistent breathlessness >28 days after acute COVID-19 infection has been identified as a highly debilitating post-COVID symptom. However, the prevalence, risk factors, mechanisms and treatments for post-COVID breathlessness remain poorly...
20.
Nithichanon A, Kewcharoenwong C, Da-Oh H, Surajinda S, Khongmee A, Koosakunwat S, et al.
Microbiol Spectr
. 2022 Oct;
10(6):e0283622.
PMID: 36227120
Infections by Acinetobacter species are recognized as a serious global threat due to causing severe disease and their high levels of antibiotic resistance. Acinetobacter baumannii is the most prevalent pathogen...